On March 27th, global biopharma company CSL opened a new R&D facility in Waltham, Massachusetts. The facility, which will be focused on next-generation vaccines, includes a BSL3 laboratory facility: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback